Article
Genetic variants in DNA repair predicts the survival of patients with esophageal cancer.
Annals of surgery - 1 May 2011
Lee Jang-Ming, Yang Pei-Wen, Yang Shi-Yi, Chuang Tzu-Hsuen, Tung En-Chi, Chen Jin-Shing, Huang Pei-Ming, Lee Yung-Chie
Abstract excerpt
OBJECTIVE: To investigate the association of the genetic variants in excision repair cross-complementation group 2 (ERCC2) R156R and ERCC4 rs3136038 with survival duration for patients with esophageal cancer. BACKGROUND: ERCC2 and ERCC4 are important molecules participating nucleotide excision repair system. The clinical relevance of the genetic variants of these genes is largely unknown currently. PATIENTS AND...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
